Philips receives FDA 510(k) clearance for its most advanced acute patient monitors
08 Dezembro 2021 - 11:00AM
Philips receives FDA 510(k) clearance for its most advanced acute
patient monitors
December 08, 2021
Philips Patient Monitors IntelliVue MX750 and IntelliVue MX850
pair with advanced software and services to offer clinical decision
support, continuous, scalable patient management and enhanced
infection control
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced that its Philips Patient Monitors MX750 and MX850 have
received 510(k) clearance from the U.S. Food and Drug
Administration. Initially cleared for Emergency Use Authorization
in 2020, the MX750 and MX850 are Philips’ most advanced patient
monitors uniquely designed to support scalability, alarm
management, cybersecurity and enhanced infection prevention within
the hospital.
As health systems navigate the digital transformation, patient
management solutions that can scale to meet hospital needs are in
high demand. The MX750 and MX850 patient monitors are an integrated
part of the company’s future-focused acute patient management
solution, enabling hospitals to standardize at a system level and
customize the solution in a particular care setting, even virtual
or decentralized, to help optimize patient care. The monitors
provide full modularity and are interoperable with other devices
and applications, including Philips Patient Information Center iX
and IntelliVue XDS software, to display critical patient data
remotely or at the point of care.
“Continuous patient monitoring plays a vital role in overall
patient safety while providing clinicians and caregivers with the
holistic view they need to best support their patients and manage
their workload,” said Sandra Lesenfants, General Manager, Hospital
Patient Monitoring, Philips. “Philips Patient Monitors IntelliVue
MX750 and MX850 are our most advanced patient monitors and a
key part of our modular portfolio of hardware, software, services
and consumables that can be tailored to provide integrated
monitoring solutions that meet the individual needs of each
healthcare provider.”
Data can also flow seamlessly between the MX750 and MX850
patient monitors and Philips Acute Care Telehealth command center
to help to simplify clinical workflow with advanced clinical
decision support, helping care teams better manage patient care
across the continuum. The integrated system securely feeds patient
data to a hospital’s electronic medical records via continuous,
best in class, end-to-end encryption, meeting the industry’s
evolving cybersecurity needs. The approach allows for virtually
gap-free patient records from admission to discharge, even during
transport, and connects care from the ICU to general ward, and
across care settings.
This FDA 510(k) clearance allows Philips’ customers to expand
their acute care and monitoring capabilities in the USA with the
same MX750 and MX850 technology that has proven successful in
hospitals across Europe since receiving CE mark in 2019.
“In the ICU, conditions can change quickly, so having access to
real-time data is important to ensure signs of deterioration are
not missed,” said Remko van den Akker, Registered Nurse, intensive
care/critical care unit, Adrz Hospital, The Netherlands. “Philips’
solutions have helped us to improve the link between essential
patient data and our hospital patient data management system, and
allow us to automatically and securely share data. This level of
interoperability has been key for successfully managing our acute
care patients.”
Philips MX750 and MX850 patient monitors also feature a rugged
design that can withstand the strongest hospital-grade
disinfectants to help minimize hospital acquired infections without
degrading the device. This helps caregivers to increase efficiency,
while ensuring high quality patient care.
To learn more about Philips’ patient monitors, please visit our
resource page on future focused monitoring.
For further information, please contact:
Anna HogrebePhilips Global Press OfficeTel: +1 416 270 67
57E-mail: anna.hogrebe@philips.com
Meredith AmorosoPhilips Global Press OfficeTel: +1
724-584-8991E-mail: meredith.amoroso@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Patient Monitors IntelliVue MX750 and IntelliVue 850 are
Philips most advanced patient monitors yet
- Patient Monitors IntelliVue MX750 and IntelliVue 850
Koninklijke Philips NV (BIT:1PHIA)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Koninklijke Philips NV (BIT:1PHIA)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024